Zemel BS, Kawchak DA, Fung EB, et. al. Effect of zinc supplementation on growth and body composition in children with sickle cell disease.
Am J Clin Nutr.
2002;75:300 - 307.
Gupta VL, Chaubey BS. Efficacy of zinc therapy in prevention of crisis in sickle-cell anemia: a double-blind, randomized controlled clinical trial.
J Assoc Physicians India.
1995;43:467 - 469.
Serjeant GR, Galloway RE, Gueri MC. Oral zinc sulphate in sickle-cell ulcers.
Lancet.
1970;2:891 - 893.
Tomer A, Kasey S, Connor WE, et al. Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids.
Thromb Haemost.
2001;85:966 - 974.
Ajayi OA, George BO, Ipadeola T. Clinical trial of riboflavin in sickle cell disease.
East Afr Med J.
1993;70:418 - 421.
al-Momen AK. Diminished vitamin B12 levels in patients with severe sickle cell disease.
J Intern Med.
1995;237:551 - 555.
Ballas SK. Short Report: Hydration of sickle erythrocytes using a herbal extract (
Pfaffia paniculata) in vitro.
Br J Haematol.
2000;111:359 - 362.
Chiu D, Vichinsky E, Ho SL, et al. Vitamin C deficiency in patients with sickle cell anemia.
Am J Pediatr Hematol Oncol.
1990;12:262 - 267.
De Franceschi L, Bachir D, Balacteros F, et al. Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease.
J Clin Invest.
1997;100:1847 - 1852.
De Franceschi L, Bachir D, Balacteros F, et al. Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease.
Br J Haematol.
2000;108:284 - 289.
Essein, EU. Plasma levels of retinol, ascorbic acid and alpha-tocopherol in sickle cell anemia.
Centr Afr J Med.
1995;41:48 - 50.
Flores L, Pais R, Buchanan I, et al. Pyridoxal 5'-phosphate levels in children with sickle cell disease.
Am J Pediatr Hematol Oncol.
1988;10:236 - 240.
Jain SK, Ross JD, Duett J, et al. Low plasma prealbumin and carotenoid levels in sickle cell disease patients.
Am J Med Sci.
1990;229:13 - 15.
Jain SK, Williams DM. Reduced levels of plasma ascorbic acid (vitamin C) in sickle cell disease patients: its possible role in the oxidant damage to sickle cells in vitro.
Clin Chim Acta.
1985;149:257 - 261.
Kark JA, Kale MP, Tarassoff PG, et al. Inhibition of erythrocyte sickling in vitro by pyridoxal.
J Clin Invest.
1978;62:888 - 891.
Kark JA, Tarassoff PG, Bongiovanni R. Pyridoxal phosphate as an antisickling agent in vitro.
J Clin Invest.
1983;71:1224 - 1229.
Muskiet FA, Muskiet FD, Meiborg G, et al. Supplementation of patients with homozygous sickle cell disease with zinc, alpha-tocopherol, vitamin C, soybean oil, and fish oil.
Am J Clin Nutr.
1991;54:736 - 744.
Natta C, Stacewicz-Sapuntzakis M, Bhagavan H, et al. Low serum levels of carotenoids in sickle cell anemia.
Eur J Haematol.
1988;41:131 - 135.
Natta CL, Machlin LJ, Brin M. A decrease in irreversibly sickled erythrocytes in sickle cell anemia patients given vitamin E.
Am J Clin Nutr.
1980;33:968 - 971.
Natta CL, Reynolds RD. Apparent vitamin B6 deficiency in sickle cell anemia.
Am J Clin Nutr.
1984;40:235 - 239.
Ndombi IO, Kinoti SN. Serum vitamin E and the sickling status in children with sickle cell anemia.
East Afr Med J.
1990;67:720 - 725.
Ohnishi ST, Ohnishi T, Ogunmola GB. Sickle cell anemia: A potential nutritional approach for a molecular disease.
Nutrition.
2000;16:330 - 338.
Osifo BO, Adeyokunnu A, Parmentier Y, et al. Abnormalities of serum transcobalamins in sickle cell disease (HbSS) in Black Africa.
Scand J Haematol.
1983;30:135 - 140.
Phillips G, Tangney CC. Relationship of plasma alpha tocopherol to index of clinical severity in individuals with sickle cell anemia.
Am J Hematol.
1992;41:227 - 231.
Reed JD, Redding-Lallinger R, Orringer EP. Nutrition and sickle cell disease.
Am J Hematol.
1987;24:441 - 455 .
Tangney CC, Phillips G, Bell RA, et al. Selected indices of micronutrient status in adult patients with sickle cell anemia (SCA).
Am J Hematol.
1989;32:161 - 166.
van der Dijs FP, Schnog JJ, Brouwer DA, et al. Elevated homocysteine levels indicate suboptimal folate status in pediatric sickle cell patients.
Am J Hematol.
1998;59:192 - 198.
Wambebe C, Khamofu H, Momoh JA, et al. Double-blind, placebo-controlled, randomised cross-over clinical trial of NIPRISAN in patients with Sickle Cell Disorder.
Phytomedicine. 2001;8:252 - 261.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.